GBT (+37% /PM) Announces U.S. FDA Agrees with its Proposal Relating to Accelerated Approval Pathway for Voxelotor for Treatment of SCD and GBT Plans to Submit NDA https://www.streetinsider.com/dr/news.php?id=14883087
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.